Baotou Dongbao Bio-Tech Co Ltd (300239) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.005x

Based on the latest financial reports, Baotou Dongbao Bio-Tech Co Ltd (300239) has a cash flow conversion efficiency ratio of 0.005x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥8.19 Million ≈ $1.20 Million USD) by net assets (CN¥1.69 Billion ≈ $247.61 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Baotou Dongbao Bio-Tech Co Ltd to measure how much of total assets are equity-financed.

Baotou Dongbao Bio-Tech Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Baotou Dongbao Bio-Tech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 300239 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Baotou Dongbao Bio-Tech Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Baotou Dongbao Bio-Tech Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Issta Lines Ltd
TA:ISTA
0.034x
CN EVERBRIGHT WATER HD 1
F:BIU2
N/A
Benitec Biopharma Ltd ADR
NASDAQ:BNTC
-0.020x
Attica Holdings S.A.
AT:ATTICA
0.023x
Jiangxi Synergy Pharmaceutical Co Ltd
SHE:300636
0.027x
Panin Financial Tbk
JK:PNLF
0.014x
Fujian Minfa Aluminium Co Ltd
SHE:002578
-0.035x
China Chippacking Technology Co. Ltd. A
SHG:688216
N/A

Annual Cash Flow Conversion Efficiency for Baotou Dongbao Bio-Tech Co Ltd (2008–2025)

The table below shows the annual cash flow conversion efficiency of Baotou Dongbao Bio-Tech Co Ltd from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Baotou Dongbao Bio-Tech Co Ltd.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥1.72 Billion
≈ $252.16 Million
CN¥105.92 Million
≈ $15.50 Million
0.061x +54.67%
2024-12-31 CN¥1.74 Billion
≈ $254.53 Million
CN¥69.13 Million
≈ $10.12 Million
0.040x -62.26%
2023-12-31 CN¥1.89 Billion
≈ $277.03 Million
CN¥199.39 Million
≈ $29.18 Million
0.105x -5.32%
2022-12-31 CN¥1.76 Billion
≈ $256.94 Million
CN¥195.32 Million
≈ $28.58 Million
0.111x +246.38%
2021-12-31 CN¥1.60 Billion
≈ $234.67 Million
CN¥51.50 Million
≈ $7.54 Million
0.032x -49.22%
2020-12-31 CN¥998.18 Million
≈ $146.07 Million
CN¥63.13 Million
≈ $9.24 Million
0.063x +250.67%
2019-12-31 CN¥991.86 Million
≈ $145.14 Million
CN¥-41.63 Million
≈ $-6.09 Million
-0.042x -152.53%
2018-12-31 CN¥750.88 Million
≈ $109.88 Million
CN¥60.00 Million
≈ $8.78 Million
0.080x +1970.83%
2017-12-31 CN¥729.75 Million
≈ $106.79 Million
CN¥-3.12 Million
≈ $-456.11K
-0.004x -107.57%
2016-12-31 CN¥718.86 Million
≈ $105.19 Million
CN¥40.54 Million
≈ $5.93 Million
0.056x -12.57%
2015-12-31 CN¥706.55 Million
≈ $103.39 Million
CN¥45.57 Million
≈ $6.67 Million
0.065x +279.51%
2014-12-31 CN¥340.56 Million
≈ $49.83 Million
CN¥-12.24 Million
≈ $-1.79 Million
-0.036x -239.04%
2013-12-31 CN¥351.47 Million
≈ $51.43 Million
CN¥9.08 Million
≈ $1.33 Million
0.026x +53.46%
2012-12-31 CN¥324.03 Million
≈ $47.42 Million
CN¥5.46 Million
≈ $798.48K
0.017x -79.42%
2011-12-31 CN¥295.99 Million
≈ $43.31 Million
CN¥24.22 Million
≈ $3.54 Million
0.082x -15.71%
2010-12-31 CN¥122.44 Million
≈ $17.92 Million
CN¥11.88 Million
≈ $1.74 Million
0.097x -29.35%
2009-12-31 CN¥100.65 Million
≈ $14.73 Million
CN¥13.83 Million
≈ $2.02 Million
0.137x +422.49%
2008-12-31 CN¥97.87 Million
≈ $14.32 Million
CN¥-4.17 Million
≈ $-610.07K
-0.043x --

About Baotou Dongbao Bio-Tech Co Ltd

SHE:300239 China Drug Manufacturers - Specialty & Generic
Market Cap
$420.43 Million
CN¥2.87 Billion CNY
Market Cap Rank
#13012 Global
#3805 in China
Share Price
CN¥4.84
Change (1 day)
+1.47%
52-Week Range
CN¥4.52 - CN¥6.63
All Time High
CN¥9.53
About

Baotou Dongbao Bio-Tech Co.,Ltd engages in the design, research and development, production, and sale of gelatin and collagen and their derivative products in the People's Republic of China and internationally. It offers pharmaceutical gelation, food additives gelatin, and photographic gelatin; hydrolyzed collagen, collagen peptide, fish collagen peptide, and agglomerated collagen; and private la… Read more